Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data.

Michel Lanteri-MinetAnne DucrosClement FrancoisElzbieta OlewinskaMateusz NikodemLaure Dupont-Benjamin

Published in: Cephalalgia : an international journal of headache (2022)

The meta-analysis reflecting real-world practice broadly corroborated with evidence from pivotal and long-term open-label studies of onabotulinumtoxinA in chronic migraine preventive treatment.

Keyphrases

systematic review
open label
healthcare
randomized controlled trial
primary care
clinical trial
electronic health record
case control
big data
study protocol
artificial intelligence
double blind
smoking cessation